Elisabet de los Pinos, Ph.D.

Elisabet de los Pinos, Ph.D.

President, Chief Executive Officer and DirectoratAura Biosciences· In proxies 2022–2025

Pay in FY2025+10% from the year before · Aura Biosciences stock -33.7% the same year

Elisabet de los Pinos, Ph.D. was paid $4.0M in FY2025 (Dec), up 10%. Aura Biosciences stock fell 33.7% that year.

Pay$100 in the stock at the end of FY21 → $32
Pay is from the Summary Compensation Table of each Aura Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aura BiosciencesPublic company · 4 yr
    • President, Chief Executive Officer and Director2022 – Present · 4 yrStock in role -64%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?